Fundamentals and stats

Key facts

—

About

Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W. Burton on August 4, 2005 and is headquartered in Ottawa, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

VIVXF has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company